查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1304388

持续血糖监测系统(CGM)设备市场:各零件，各终端用户，各地区-市场规模，占有率，展望，机会分析，2023～2030年

Continuous Glucose Monitoring Devices Market, By Component, By End User, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态:

糖尿病患病率的增加、老年人口的增加、对连续血糖监测仪 (CGM) 的需求不断增加、技术先进设备的日益采用以及全球人们意识的提高是预计促进全球连续血糖监测设备市场增长的主要因素。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球持续血糖监测系统(CGM)设备市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球持续血糖监测系统(CGM)设备市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球持续血糖监测系统(CGM)设备市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球持续血糖监测系统(CGM)设备市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

  • 市场动态
    • 全世界增加糖尿病盛行率
    • 持续血糖监测仪的高成本
    • 持续血糖监测仪的需求增加
  • 影响分析
  • 主要的焦点
  • 法规情势
  • 产品销售/核准
  • PEST分析
  • 波特分析
  • 合併·收购情势

第4章 持续血糖监测系统(CGM)设备市场-冠状病毒(COVID-19)流行的影响

  • COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 持续血糖监测系统(CGM)设备市场:各零件，2018-2030年

  • 感测器
  • 发射器
  • 接收器

第6章 持续血糖监测系统(CGM)设备市场:各终端用户，2018年～2030年

  • 医院
  • 居家医疗
  • 其他

第7章 持续血糖监测系统(CGM)设备市场:各地区，2018年-2030年

  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第8章 竞争情形

  • Medtronic
  • Dexcom, Inc.
  • Abbott
  • Novo Nordisk A/S
  • Ypsomed
  • GlySens Incorporated
  • F. Hoffmann-La Roche Ltd.

第9章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI57

Continuous glucose monitor (CGM) is a medical device used by people with diabetes to monitor blood sugar (glucose) on a continual basis, e.g. people with type I, type II diabetes, or other types of diabetes (e.g. gestational diabetes). Thus, with the increasing prevalence of diabetes across the globe, the demand for CGM devices is also increasing rapidly, worldwide.

Market Dynamics:

Increasing prevalence of diabetes, growing geriatric population, increasing demand for continuous glucose monitors (CGM), increasing adoption of technologically advanced devices, and increasing awareness among people across the globe are major factors expected to augment the growth of thelobal continuous glucose monitoring devices market.

For instance, in May 2023, Health tech company, January AI, introduced a new generative artificial intelligence (AI)-enabled app to estimate and predict the glucose response of individuals to more than 32 Billion food items. The tool requires users to wear a CGM only once and it can function even if members are not using a CGM. The platform is designed to provide users with information such as glucose estimates, predictions and key insights on an ongoing basis. Users also receive insights on increasing fibre consumption, calorie recommendations, intermittent fasting, lowering glucose-spiking foods, and getting post-meal walks.

Key features of the study:

  • This report provides in-depth analysis of the global continuous glucose monitoring devices market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global continuous glucose monitoring devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Medtronic, Dexcom, Inc., Abbott, Novo Nordisk A/S, Ypsomed, GlySens Incorporated, and F. Hoffmann-La Roche Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous glucose monitoring device market.

Detailed Segmentation:

  • Global Continuous Glucose Monitoring Devices Market, By Component:
    • Sensors
    • Transmitters
    • Receivers
  • Global Continuous Glucose Monitoring Devices Market, By End User:
    • Hospitals
    • Home care
    • Others
  • Global Continuous Glucose Monitoring Devices Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Medtronic
    • Dexcom, Inc.
    • Abbott
    • Novo Nordisk A/S
    • Ypsomed
    • GlySens Incorporated
    • F.Hoffmann-La Roche Ltd.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Component
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of diabetes around the world
    • High cost of continuous glucose monitors
    • Increasing demand for continuous glucose monitors
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Continuous Glucose Monitoring Devices Mask Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Continuous Glucose Monitoring Devices Market, By Component, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Transmitters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Receivers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Continuous Glucose Monitoring Devices Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Home care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Continuous Glucose Monitoring Devices Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ypsomed
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlySens Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us